SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Scott Weiner is participating on a panel at the Greater Philadelphia Alliance for Capital and Technologies IMPACT 2010 Conference in Philadelphia, PA
News | 11. 09. 2010
